I am so blessed to have caring friends and readers. I did not see this setback coming.
They say read it and weep.
I have wept.
I am getting ready to fight again .
But ensure they are tears of joy!
The braf keytruda experiment a disaster.
Back to survival basics.
Still here smiling but scared!
I went to visit mum ashes at cemetery. Alas they have been moved without my knowledge. A big fight apparently i missed. My ashes are here scattered in this blog.
MY EMAIL TO GERMANS
Im unusually silent.
Lost for words except today is the best day of my life.
Flight booked 1st september unless you want me sooner in germany but 50th birthday on 25th so ill celebrate that and ask god for ever increasing miracles.
These new tumours most perplexing
Cheers,
Pete
Report:
The patient was scanned 63 minutes after the i.v.i of 361 MBq of FDG with their arms at their side, from head to mid thighs. The scan was completed on a 128-slice mCT scanner with high definition reconstruction, continuous bed motion and time-of-flight technology. The current study was compared to the previous study from April 2016.
There are no large mass lesions in the brain; there are no abnormalities in the scalp or the skull. The nasopharynx is clear as is the oropharynx and there are no abnormalities in cervical lymph nodes.
There has been a marked change in the interval since the last scan in the liver. The lesion which was seen previously in segment seven is larger and heterogeneous; it has diameter of 30 mm, there is central glucose hypometabolism and a rim of increased metabolism at 8.9-if this lesion has been treated the rim of increased metabolism could reflect inflammation or active disease. There are multiple other new sites of disease however in the rest of the liver. There are at least 12 new sites of disease scattered throughout the residual liver but they are mainly concentrated in segments four, eight, five and seven. There are no discrete abnormalities in lymph nodes at the porta hepatis and there are no abnormalities in epigastric lymph nodes. The spleen is normal. Paracaval, paraaortic and mesenteric nodes in the abdomen are clear. There is however a new focal region of increased metabolism in the right posterior pelvis in what I think reflects a 12 mm diameter lymph node just to
the right of the midline at the level of S5, peak metabolism is 15.1; this abnormality was not evident on the last scan. Above the diaphragm the rounded nodules seen in both lung fields on the last scan are slightly larger and slightly more mildly glucose avid. Lymph nodes at the base of the neck are clear. The bony skeleton is clear. The remainder of the study is normal.
Conclusions:
There has been a marked change in the interval since the last scan and there are now multiple new regions of abnormal metabolism in the liver consistent with new sites of disease. There is also focal FDG uptake in a lymph node in the right side of the pelvis posteriorly which I suspect is another site of disease. The multiple nodules in the lung fields are slightly larger and slightly more glucose avid.
The patient was scanned 63 minutes after the i.v.i of 361 MBq of FDG with their arms at their side, from head to mid thighs. The scan was completed on a 128-slice mCT scanner with high definition reconstruction, continuous bed motion and time-of-flight technology. The current study was compared to the previous study from April 2016.
There are no large mass lesions in the brain; there are no abnormalities in the scalp or the skull. The nasopharynx is clear as is the oropharynx and there are no abnormalities in cervical lymph nodes.
There has been a marked change in the interval since the last scan in the liver. The lesion which was seen previously in segment seven is larger and heterogeneous; it has diameter of 30 mm, there is central glucose hypometabolism and a rim of increased metabolism at 8.9-if this lesion has been treated the rim of increased metabolism could reflect inflammation or active disease. There are multiple other new sites of disease however in the rest of the liver. There are at least 12 new sites of disease scattered throughout the residual liver but they are mainly concentrated in segments four, eight, five and seven. There are no discrete abnormalities in lymph nodes at the porta hepatis and there are no abnormalities in epigastric lymph nodes. The spleen is normal. Paracaval, paraaortic and mesenteric nodes in the abdomen are clear. There is however a new focal region of increased metabolism in the right posterior pelvis in what I think reflects a 12 mm diameter lymph node just to
the right of the midline at the level of S5, peak metabolism is 15.1; this abnormality was not evident on the last scan. Above the diaphragm the rounded nodules seen in both lung fields on the last scan are slightly larger and slightly more mildly glucose avid. Lymph nodes at the base of the neck are clear. The bony skeleton is clear. The remainder of the study is normal.
Conclusions:
There has been a marked change in the interval since the last scan and there are now multiple new regions of abnormal metabolism in the liver consistent with new sites of disease. There is also focal FDG uptake in a lymph node in the right side of the pelvis posteriorly which I suspect is another site of disease. The multiple nodules in the lung fields are slightly larger and slightly more glucose avid.
